The main objective of the study is to determine the proportion of patients with M + mutation status among patients with Non Small Cell Lung Cancer adenocarcinoma.
MSD
Study Type
OBSERVATIONAL
Enrollment
2,000
The main objective of the study is to determine the proportion of patients with M + mutation status among patients with NSCLC adenocarcinoma
Time frame: At baseline
Describe the therapeutic management according to the mutational status (EGFR M +, EGFR M- and Mx).
Time frame: 12 months / At each visit
Describe the therapeutic management of patients with EGFR M +.
Time frame: 12 months / At each visit
Describe the clinical course of patients EGFR-M +, treated for first-line treatment, and then 2nd line treatment, until 31-AUG-2012
Time frame: 12 months / At each visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Abbeville, France
Research Site
Aix-en-Provence, France
Research Site
Amilly, France
Research Site
Angers, France
Research Site
Antibes, France
Research Site
Arras, France
Research Site
Aulnay-sous-Bois, France
Research Site
Auxerre, France
Research Site
Bastia, France
Research Site
Bayonne, France
...and 91 more locations